Group 1 - The core viewpoint of the news is that 联影医疗 (United Imaging Healthcare) experienced a decline in stock price, dropping by 5.01% to 141.39 yuan per share, with a trading volume of 715 million yuan and a turnover rate of 0.60%, resulting in a total market capitalization of 116.528 billion yuan [1] - 联影医疗, established on March 21, 2011, and listed on August 22, 2022, specializes in high-performance medical imaging equipment, radiation therapy products, life science instruments, and medical digital and intelligent solutions [1] - The company's revenue composition includes 81.99% from sales of medical imaging diagnostic equipment and radiation therapy equipment, 13.16% from maintenance services, 4.04% from other sources, and 0.81% from software [1] Group 2 - From the perspective of fund holdings, 国联基金 (Guolian Fund) has one fund heavily invested in 联影医疗, specifically the 国联上证科创板综合指数增强A (023911), which held 8,800 shares, accounting for 0.22% of the fund's net value, ranking as the ninth largest holding [2] - The fund has a current scale of 430 million yuan and has achieved a return of 24.31% since its inception on June 4, 2025 [2] - The fund managers, 王喆 and 黄磊鑫, have different tenures and performance records, with 王喆 having a tenure of 6 years and 295 days, managing assets totaling 1.657 billion yuan, and 黄磊鑫 with a tenure of 147 days managing 831 million yuan [2]
联影医疗股价跌5.01%,国联基金旗下1只基金重仓,持有8800股浮亏损失6.56万元